Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ANK2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLIT1-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
SLC8A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
COL11A2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C11orf40 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LYL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMNL2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
SIGLEC10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PYY - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IL31RA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
HOXA7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFKBIB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SHF - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
IFITM10 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SLC22A17 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF653 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on